Cargando…

Aberrant expression of CD133 and CD82 in patients with pediatric acute lymphoblastic leukemia and the clinical significance

Cluster of differentiation (CD)133 is considered to be a marker of leukemia stem cells (LSCs), which are one of the primary causes of occurrence, drug resistance and relapse of acute lymphoblastic leukemia (ALL). CD82, an adhesion molecule, performs an important role in the interaction between LSCs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Hongyan, Chen, Li, Dai, Yunpeng, Sun, Xiaojun, Li, Xiuli, Wang, Qi, Ma, Daoxin, Du, Dongdong, Zhao, Ping, Wang, Yulin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661600/ https://www.ncbi.nlm.nih.gov/pubmed/29113211 http://dx.doi.org/10.3892/ol.2017.6981

Ejemplares similares

Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma
por: Yu, Lan, et al.
Publicado: (2014)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

Prognostic significance of aberrant CD5 expression in B-cell leukemia
por: Jaseb, Kaveh, et al.
Publicado: (2019)

An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia
por: Riegg, Fabian, et al.
Publicado: (2021)

Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
por: Han, Zhengquan, et al.
Publicado: (2015)

The Significance of CD20 Intensity Variance in Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia
por: Serbanica, Andreea Nicoleta, et al.
Publicado: (2023)

CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia
por: Jiang, Zhiwu, et al.
Publicado: (2016)

Clinical significance of KAI1/CD82 protein expression in nasopharyngeal carcinoma
por: WANG, GENGMING, et al.
Publicado: (2015)

Significance of CD133 expression in esophageal squamous cell carcinoma
por: Okamoto, Hiroshi, et al.
Publicado: (2013)

Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry
por: Wu, Shiwu, et al.
Publicado: (2012)

The prognostic significance of hematogones and CD34+ myeloblasts in bone marrow for adult B-cell lymphoblastic leukemia without minimal residual disease
por: Liao, Hongyan, et al.
Publicado: (2019)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
por: Dai, Hanren, et al.
Publicado: (2020)

CD82 and Gangliosides Tune CD81 Membrane Behavior
por: Fernandez, Laurent, et al.
Publicado: (2021)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

Immunophenotypic markers in adult acute lymphoblastic leukemia: the prognostic significance of CD20 and TdT expression
por: Kim, Dae-Young, et al.
Publicado: (2015)

Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
por: Dai, Hanren, et al.
Publicado: (2020)

CD45(dim)CD34(+)CD38(−)CD133(+) cells have the potential as leukemic stem cells in acute myeloid leukemia
por: Heo, Sook-Kyoung, et al.
Publicado: (2020)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma
por: Zhao, Po, et al.
Publicado: (2010)

Tetraspanin CD82 Regulates the Spatiotemporal Dynamics of PKCα in Acute Myeloid Leukemia
por: Termini, Christina M., et al.
Publicado: (2016)

Aberrant GATA2 Activation in Pediatric B-Cell Acute Lymphoblastic Leukemia
por: Wang, Han, et al.
Publicado: (2022)

The Expression and Prognostic Impact of CD95 Death Receptor and CD20, CD34 and CD44 Differentiation Markers in Pediatric Acute Lymphoblastic Leukemia
por: M. Kamazani, Fatemeh, et al.
Publicado: (2014)

Isolation, identification and expression of specific human CD133 antibodies
por: Xia, Jing, et al.
Publicado: (2013)

Prognostic significance of CD133 and ABCB5 expression in papillary thyroid carcinoma
por: Karas Zella, Maria Augusta, et al.
Publicado: (2020)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Aberrant EPHB4 gene methylation and childhood acute lymphoblastic leukemia
por: Li, Yuhua, et al.
Publicado: (2017)

Heterogeneity of CD34 and CD38 expression in acute B lymphoblastic leukemia cells is reversible and not hierarchically organized
por: Jiang, Zhiwu, et al.
Publicado: (2016)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

CD133 Role in Oral Carcinogenesis
por: Luna, Ealber Carvalho Macedo, et al.
Publicado: (2020)

High Expression of Interleukin-3 Receptor Alpha Chain (CD123) Predicts Favorable Outcome in Pediatric B-Cell Acute Lymphoblastic Leukemia Lacking Prognosis-Defining Genomic Aberrations
por: Li, Zhiheng, et al.
Publicado: (2021)

Prognostic Role of CD200 in Acute Lymphoblastic Leukemia Patients
por: Khalil, Mohamed, et al.
Publicado: (2023)

Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis
por: Durko, L., et al.
Publicado: (2017)

CD133 in brain tumor: the prognostic factor
por: Li, Bin, et al.
Publicado: (2016)

Can CD34(+)CD38(−) lymphoblasts, as likely leukemia stem cells, be a prognostic factor in B-cell precursor acute lymphoblastic leukemia in children?
por: Stolpa, Weronika, et al.
Publicado: (2023)

Preliminary Study on the Expression and the Clinical Significance of CD133 in Peripheral Blood of Patients with Gastric Adenocarcinoma
por: Wu, Ju-gang, et al.
Publicado: (2014)

Viability and intracellular nitric oxide generation in the umbilical cord blood CD34(+)CD133(–) and CD34(+)CD133(+) cell populations exposed to local anaesthetics
por: Kulińska, Karolina I., et al.
Publicado: (2021)

Clinical Significance of Cancer Stem Cell Markers CD133 and CXCR4 in Osteosarcomas
por: Mardani, Azam, et al.
Publicado: (2020)

Clinical significance of CD133 and Nestin in astrocytic tumor: The correlation with pathological grade and survival
por: Zhang, Qingping, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e58c6pc66g8p9m71e5u78knqkq